Premalignant Lesions as Targets for Cancer Vaccines

This publication has 36 references indexed in Scilit:

• Vigorous Premalignancy-specific Effector T Cell Response in the Bone Marrow of Patients with Monoclonal Gammopathy
  The Journal of Experimental Medicine, 2003
• Cancer vaccines: between the idea and the reality
  Nature Reviews Immunology, 2003
• Complex Carbohydrates Are Not Removed During Processing of Glycoproteins by Dendritic Cells
  The Journal of Experimental Medicine, 2002
• Cancer immunoediting: from immunosurveillance to tumor escape
  Nature Immunology, 2002
• The Danger Model: A Renewed Sense of Self
  Science, 2002
• Prophylactic cancer vaccines
  Current Opinion in Immunology, 2002
• A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance
  New England Journal of Medicine, 2002
• Pancreatic Intraepithelial Neoplasia
  The American Journal of Surgical Pathology, 2001
• Precancerous conditions for pancreatic cancer
  Journal of Hepato-Biliary-Pancreatic Surgery, 2000
• p53 Mutations in Human Cancers
  Science, 1991